Comprehensive Multimodal Deep Learning Survival Prediction Enabled by a Transformer Architecture: A Multicenter Study in Glioblastoma
2405.12963
0
0
🤿
Abstract
Background: This research aims to improve glioblastoma survival prediction by integrating MR images, clinical and molecular-pathologic data in a transformer-based deep learning model, addressing data heterogeneity and performance generalizability. Method: We propose and evaluate a transformer-based non-linear and non-proportional survival prediction model. The model employs self-supervised learning techniques to effectively encode the high-dimensional MRI input for integration with non-imaging data using cross-attention. To demonstrate model generalizability, the model is assessed with the time-dependent concordance index (Cdt) in two training setups using three independent public test sets: UPenn-GBM, UCSF-PDGM, and RHUH-GBM, each comprising 378, 366, and 36 cases, respectively. Results: The proposed transformer model achieved promising performance for imaging as well as non-imaging data, effectively integrating both modalities for enhanced performance (UPenn-GBM test-set, imaging Cdt 0.645, multimodal Cdt 0.707) while outperforming state-of-the-art late-fusion 3D-CNN-based models. Consistent performance was observed across the three independent multicenter test sets with Cdt values of 0.707 (UPenn-GBM, internal test set), 0.672 (UCSF-PDGM, first external test set) and 0.618 (RHUH-GBM, second external test set). The model achieved significant discrimination between patients with favorable and unfavorable survival for all three datasets (logrank p 1.9times{10}^{-8}, 9.7times{10}^{-3}, and 1.2times{10}^{-2}). Conclusions: The proposed transformer-based survival prediction model integrates complementary information from diverse input modalities, contributing to improved glioblastoma survival prediction compared to state-of-the-art methods. Consistent performance was observed across institutions supporting model generalizability.
Create account to get full access
Overview
- This research aims to improve glioblastoma survival prediction using a transformer-based deep learning model.
- The model integrates MRI images, clinical data, and molecular-pathological data to address data heterogeneity and improve performance generalization.
- The researchers evaluate the model's performance on three independent public test sets, demonstrating consistent and promising results.
Plain English Explanation
This research focuses on improving the prediction of survival time for patients with glioblastoma, a type of brain cancer. The researchers developed a transformer-based deep learning model that combines information from multiple sources - MRI scans, clinical data, and molecular-pathological data - to make more accurate predictions.
The key idea is that by using a transformer-based architecture, the model can effectively encode and integrate the diverse data types, which improves the overall performance compared to previous methods that struggled to handle this data heterogeneity.
To demonstrate the model's generalizability, the researchers tested it on three independent datasets from different institutions, showing consistent and reliable performance. This is important because it suggests the model could be used in real-world clinical settings, not just in the lab.
Overall, this research represents an important step in developing more accurate and robust predictive models for glioblastoma, which could ultimately help healthcare providers make better-informed decisions about patient care and treatment.
Technical Explanation
The researchers propose a transformer-based non-linear and non-proportional survival prediction model for glioblastoma. The model uses self-supervised learning techniques to effectively encode the high-dimensional MRI input, which is then integrated with the non-imaging data (clinical and molecular-pathological) using cross-attention.
To evaluate the model's performance, the researchers assessed it using the time-dependent concordance index (Cdt) metric on three independent public test sets: UPenn-GBM, UCSF-PDGM, and RHUH-GBM, comprising 378, 366, and 36 cases, respectively.
The proposed transformer model achieved promising performance for both imaging and non-imaging data, with the multimodal approach outperforming state-of-the-art late-fusion 3D-CNN-based models. The model demonstrated consistent performance across the three independent multicenter test sets, with Cdt values of 0.707 (UPenn-GBM, internal test set), 0.672 (UCSF-PDGM, first external test set), and 0.618 (RHUH-GBM, second external test set).
Furthermore, the model was able to significantly discriminate between patients with favorable and unfavorable survival for all three datasets (logrank p 1.9×10^-8, 9.7×10^-3, and 1.2×10^-2).
Critical Analysis
The researchers have addressed an important challenge in integrating multimodal data for improved predictive modeling in oncology. By using a transformer-based architecture, they have demonstrated the ability to effectively encode and combine diverse data types, leading to enhanced glioblastoma survival prediction compared to previous state-of-the-art methods.
One potential limitation is the relatively small size of the RHUH-GBM dataset, which may have contributed to the lower Cdt value observed for that test set. Additionally, the researchers did not provide insights into the specific contributions of each data modality to the model's performance, which could be valuable for understanding the relative importance of different types of data.
Further research could explore optimizing the model architecture or investigating alternative ways of integrating the data modalities, potentially leading to even stronger predictive performance. Additionally, validating the model's performance on larger and more diverse datasets would help solidify its generalizability and real-world applicability.
Conclusion
This research presents a promising transformer-based deep learning model for improving glioblastoma survival prediction by effectively integrating MRI images, clinical data, and molecular-pathological information. The model's consistent performance across multiple independent test sets suggests its potential for clinical translation and improved patient care.
The ability to accurately predict survival for glioblastoma patients could help healthcare providers make more informed decisions about treatment options and palliative care, ultimately leading to better outcomes for individuals diagnosed with this devastating disease.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🔮
FORESEE: Multimodal and Multi-view Representation Learning for Robust Prediction of Cancer Survival
Liangrui Pan, Yijun Peng, Yan Li, Yiyi Liang, Liwen Xu, Qingchun Liang, Shaoliang Peng
0
0
Integrating the different data modalities of cancer patients can significantly improve the predictive performance of patient survival. However, most existing methods ignore the simultaneous utilization of rich semantic features at different scales in pathology images. When collecting multimodal data and extracting features, there is a likelihood of encountering intra-modality missing data, introducing noise into the multimodal data. To address these challenges, this paper proposes a new end-to-end framework, FORESEE, for robustly predicting patient survival by mining multimodal information. Specifically, the cross-fusion transformer effectively utilizes features at the cellular level, tissue level, and tumor heterogeneity level to correlate prognosis through a cross-scale feature cross-fusion method. This enhances the ability of pathological image feature representation. Secondly, the hybrid attention encoder (HAE) uses the denoising contextual attention module to obtain the contextual relationship features and local detail features of the molecular data. HAE's channel attention module obtains global features of molecular data. Furthermore, to address the issue of missing information within modalities, we propose an asymmetrically masked triplet masked autoencoder to reconstruct lost information within modalities. Extensive experiments demonstrate the superiority of our method over state-of-the-art methods on four benchmark datasets in both complete and missing settings.
5/14/2024
🏷️
Transformer-Based Classification Outcome Prediction for Multimodal Stroke Treatment
Danqing Ma, Meng Wang, Ao Xiang, Zongqing Qi, Qin Yang
0
0
This study proposes a multi-modal fusion framework Multitrans based on the Transformer architecture and self-attention mechanism. This architecture combines the study of non-contrast computed tomography (NCCT) images and discharge diagnosis reports of patients undergoing stroke treatment, using a variety of methods based on Transformer architecture approach to predicting functional outcomes of stroke treatment. The results show that the performance of single-modal text classification is significantly better than single-modal image classification, but the effect of multi-modal combination is better than any single modality. Although the Transformer model only performs worse on imaging data, when combined with clinical meta-diagnostic information, both can learn better complementary information and make good contributions to accurately predicting stroke treatment effects..
4/22/2024
MM-GTUNets: Unified Multi-Modal Graph Deep Learning for Brain Disorders Prediction
Luhui Cai, Weiming Zeng, Hongyu Chen, Hua Zhang, Yueyang Li, Hongjie Yan, Lingbin Bian, Nizhuan Wang
0
0
Graph deep learning (GDL) has demonstrated impressive performance in predicting population-based brain disorders (BDs) through the integration of both imaging and non-imaging data. However, the effectiveness of GDL based methods heavily depends on the quality of modeling the multi-modal population graphs and tends to degrade as the graph scale increases. Furthermore, these methods often constrain interactions between imaging and non-imaging data to node-edge interactions within the graph, overlooking complex inter-modal correlations, leading to suboptimal outcomes. To overcome these challenges, we propose MM-GTUNets, an end-to-end graph transformer based multi-modal graph deep learning (MMGDL) framework designed for brain disorders prediction at large scale. Specifically, to effectively leverage rich multi-modal information related to diseases, we introduce Modality Reward Representation Learning (MRRL) which adaptively constructs population graphs using a reward system. Additionally, we employ variational autoencoder to reconstruct latent representations of non-imaging features aligned with imaging features. Based on this, we propose Adaptive Cross-Modal Graph Learning (ACMGL), which captures critical modality-specific and modality-shared features through a unified GTUNet encoder taking advantages of Graph UNet and Graph Transformer, and feature fusion module. We validated our method on two public multi-modal datasets ABIDE and ADHD-200, demonstrating its superior performance in diagnosing BDs. Our code is available at https://github.com/NZWANG/MM-GTUNets.
6/21/2024
🤿
An Optimized Ensemble Deep Learning Model For Brain Tumor Classification
Md. Alamin Talukder, Md. Manowarul Islam, Md Ashraf Uddin
0
0
Brain tumors present a grave risk to human life, demanding precise and timely diagnosis for effective treatment. Inaccurate identification of brain tumors can significantly diminish life expectancy, underscoring the critical need for precise diagnostic methods. Manual identification of brain tumors within vast Magnetic Resonance Imaging (MRI) image datasets is arduous and time-consuming. Thus, the development of a reliable deep learning (DL) model is essential to enhance diagnostic accuracy and ultimately save lives. This study introduces an innovative optimization-based deep ensemble approach employing transfer learning (TL) to efficiently classify brain tumors. Our methodology includes meticulous preprocessing, reconstruction of TL architectures, fine-tuning, and ensemble DL models utilizing weighted optimization techniques such as Genetic Algorithm-based Weight Optimization (GAWO) and Grid Search-based Weight Optimization (GSWO). Experimentation is conducted on the Figshare Contrast-Enhanced MRI (CE-MRI) brain tumor dataset, comprising 3064 images. Our approach achieves notable accuracy scores, with Xception, ResNet50V2, ResNet152V2, InceptionResNetV2, GAWO, and GSWO attaining 99.42%, 98.37%, 98.22%, 98.26%, 99.71%, and 99.76% accuracy, respectively. Notably, GSWO demonstrates superior accuracy, averaging 99.76% accuracy across five folds on the Figshare CE-MRI brain tumor dataset. The comparative analysis highlights the significant performance enhancement of our proposed model over existing counterparts. In conclusion, our optimized deep ensemble model exhibits exceptional accuracy in swiftly classifying brain tumors. Furthermore, it has the potential to assist neurologists and clinicians in making accurate and immediate diagnostic decisions.
5/7/2024